Biotech Analysts Kluska & Agrawal discuss the Alpha-1 Antitrypsin Deficiency landscape and clinical development from companies under coverage (MREO ARWR BEAM NTLA VRTX) on an Analyst/Industry conference call to be held on January 30 at 1:30 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MREO:
